Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Arzneimittel-Forschung
|
January 1, 1980
Classical neuroleptics and deconditioning activity after single or repeated treatment. Role of different cerebral neurotransmitters
G B Fregnan, T Chieli
Pharmacological Research Communications
|
July 1, 1979
Inhibition of conditioned avoidance response by a new neuroleptic (LR 511). Interference with drugs endowed with different CNS activity
T Chieli, G B Fregnan
Pharmacological Research Communications
|
June 1, 1975
The effect of a new anti-inflammatory agent, the ethoxy methyl ester of N-(2,6-dichloro-m-tolyl)-anthranilic acid (A3), on platelet behaviour "in vivo" and "in vitro"
G B Fregnan, T Chieli
European Journal of Toxicology
|
September 1, 1971
[Formocortal: experimental study of its acute and chronic toxicity]
C Bertazzoli, T Chieli, G Ricevuti
Experientia
|
October 15, 1971
Different incidence of breast carcinomas or fibroadenomas in daunomycin or adriamycin treated rats
C Bertazzoli, T Chieli, E Solcia
Experientia
|
April 15, 1970
Adriamycin: toxicity data
C Bertazzoli, T Chieli, M Grandi, et al.
Bollettino Chimico Farmaceutico
|
January 1, 1976
[Toxicity and collateral pharmacological effects of A 3: a new non-steroid anti-inflammatory agent]
T Chieli, G B Fregnan, L Frigerio, et al.
Experientia
|
April 15, 1980
Neuroleptic-induced prolactin rise: influence of pharmacological alterations of different neurotransmitter system
T Chieli, D Cocchi, G B Fregnan, et al.
Bollettino Chimico Farmaceutico
|
March 1, 1974
[Remote toxic effects of antineoplastic antibiotics]
T Chieli, C Bertazzoli, L Sala, et al.
Toxicology and Applied Pharmacology
|
March 1, 1972
Chronic toxicity of adriamycin: a new antineoplastic antibiotic
C Bertazzoli, T Chieli, G Ferni, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Arzneimittel-Forschung
|
January 1, 1980
Classical neuroleptics and deconditioning activity after single or repeated treatment. Role of different cerebral neurotransmitters
G B Fregnan, T Chieli
Pharmacological Research Communications
|
July 1, 1979
Inhibition of conditioned avoidance response by a new neuroleptic (LR 511). Interference with drugs endowed with different CNS activity
T Chieli, G B Fregnan
Pharmacological Research Communications
|
June 1, 1975
The effect of a new anti-inflammatory agent, the ethoxy methyl ester of N-(2,6-dichloro-m-tolyl)-anthranilic acid (A3), on platelet behaviour "in vivo" and "in vitro"
G B Fregnan, T Chieli
European Journal of Toxicology
|
September 1, 1971
[Formocortal: experimental study of its acute and chronic toxicity]
C Bertazzoli, T Chieli, G Ricevuti
Experientia
|
October 15, 1971
Different incidence of breast carcinomas or fibroadenomas in daunomycin or adriamycin treated rats
C Bertazzoli, T Chieli, E Solcia
Experientia
|
April 15, 1970
Adriamycin: toxicity data
C Bertazzoli, T Chieli, M Grandi, et al.
Bollettino Chimico Farmaceutico
|
January 1, 1976
[Toxicity and collateral pharmacological effects of A 3: a new non-steroid anti-inflammatory agent]
T Chieli, G B Fregnan, L Frigerio, et al.
Experientia
|
April 15, 1980
Neuroleptic-induced prolactin rise: influence of pharmacological alterations of different neurotransmitter system
T Chieli, D Cocchi, G B Fregnan, et al.
Bollettino Chimico Farmaceutico
|
March 1, 1974
[Remote toxic effects of antineoplastic antibiotics]
T Chieli, C Bertazzoli, L Sala, et al.
Toxicology and Applied Pharmacology
|
March 1, 1972
Chronic toxicity of adriamycin: a new antineoplastic antibiotic
C Bertazzoli, T Chieli, G Ferni, et al.
Page
of 2